How will immune tolerance protocols affect self-sufficiency goals?

Publisher Website
Google Scholar
Abstract
Inhibitor development is a serious complication in haemophilia, and its treatment, immune tolerance therapy, is an expensive part of haemophilia treatment. However, the therapy can lead to an increased lifespan and improved quality of life. If commenced sufficiently early in the disease, it can help to reduce the overall amount of factor VIII concentrate, or other plasma derived therapeutic agents required during life.

This publication has 0 references indexed in Scilit: